1 Chapter 14 Cell-Mediated Effector Responses Cell-mediated immunity Effector role – detect and eliminate cells infected with intracellular pathogens Two types: 1) Cytotoxic T cell response: - Cytotoxic T cells (CTLs) to kill virus- infected and altered self-cells. - NK cells and Macrophages 2) Delayed-type hypersensitivity (DTH): CD4 T cells that activate macrophages to enhance killing of intracellular bacteria. ** ** CD2 (LFA-3) and LFA-1 (ICAM-1) Naïve VS Effector cells The CTL response Mediated by CD8+ cytotoxic T lymphocytes. - CD8+ T cells that have not yet seen antigen are not cytotoxic - they are referred to as precursor-CTL (CTL-P). In order to become cytotoxic effector cells, CTL-P must: - recognize antigen presented on class I MHC - express IL-2 receptors - receive IL-2 (usually from a helper T cell) - proliferate - differentiate into effector CTL FIG 14-1 NOTE: Expression of IL-2 receptors occurs only after CTL-P (precursor) activation by antigen. IL-2 from helper T cells is usually required before CTL-P can proliferate and differentiate into effector CTL (though Ag-activated CTL-P can produce some IL-2). 1 3 4 2 5 Memory CTL-Ps secrete enough IL-2 for own proliferation
6
Embed
Cell-mediated immunity - Northern Arizona Universityfpm/immunology/lectures/Chapter014.pdf · - DTH is a second major form of cell-mediated immunity. - As with humoral immunity and
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Chapter 14
Cell-Mediated Effector Responses
Cell-mediated immunity
Effector role – detect and eliminate cells infected with intracellular pathogens
Two types:
1) Cytotoxic T cell response: - Cytotoxic T cells (CTLs) to kill virus-
infected and altered self-cells.
- NK cells and Macrophages
2) Delayed-type hypersensitivity (DTH): CD4 T cells that activate macrophages to enhance killing of intracellular
bacteria.
**
**
CD2 (LFA-3) and LFA-1 (ICAM-1)
Naïve VS Effector cells The CTL response
Mediated by CD8+ cytotoxic T lymphocytes.
- CD8+ T cells that have not yet seen antigen are not cytotoxic - they
are referred to as precursor-CTL (CTL-P).
In order to become cytotoxic effector cells, CTL-P must:
- recognize antigen presented on class I MHC- express IL-2 receptors
- receive IL-2 (usually from a helper T cell)- proliferate
- differentiate into effector CTL
FIG 14-1
NOTE:
Expression of IL-2
receptors occurs only after CTL-P (precursor)
activation by antigen.
IL-2 from helper T cells is usually required
before CTL-P can
proliferate and differentiate into
effector CTL (though Ag-activated CTL-P can
produce some IL-2).
1 3
4
2
5
Memory CTL-Ps secrete enough IL-2 for
own proliferation
2
Th cells provide IL-2 for proliferation of
naïve CTL-Ps Killing by CTLs
• Lytic activity mediated by Perforin and
Granzymes
• Fas-mediated
• Working together or independently
Fig 14-9
The two pathways of CTL-mediated killing:
1
2
1) Effector CTL form tight conjugates with target cells. Contents of CTL cytoplasmic granules are released into the intercellular space. These kill
the target cell.
2) The CTL dissociates from the target cell and is able to then kill further target cells.
Fig 14-7
1) CTL cytoplasmic granules contain perforin, which can form pores in the
target cell membrane.
2) These pores allow other toxic molecules released by the CTL to enter the target cell and induce it to undergo apoptosis. 1
2
3
Natural Killer (NK) Cells
• Make up 5-10% of circulating lymphocytes
• Originate from lymphoid lineage
• First line of defense against viruses,
tumors and intracellular bacteria
• Main source of IFN-γ early during infection
• This IFN-γ can direct Th responses towards Th1-type
• Stimulated by IFN-α/IFN-β and IL-12
NK Cells and T cells
• Express unique markers:– CD2 (receptors for LFA-3)
– CD16 (FcγRIII)
– CD56 (adhesion molecule)
• Do not undergo maturation in the thymus
• Present in mice lacking thymus
• Lack CD3-TCR
• Do not show MHC-restriction
• Do not require activation
Killing by NK cells
• Similar to CTLs
• Presence of two types of receptors:
activating receptors and inhibitory receptor
• Activating receptors: NKR-P1 (C-type
lectin), CD2, FcγRIII, and NKp30, NKp44, NKp46
• Inhibitory receptor:
– C-type-lectin inhibitory receptors (CLIR):
CD94/NKG2
– Killer cell-inhibitory receptors (KIR)
Opposing Signal Model in NK cells (Activation VS Inhibitory)
macrophages, monocytes, neutrophils and eosinophils
• Killing is mediated by release of: lytic
enzymes, TNF-α, perforin and granzymes
4
5
4
3 2
1
Experimental Assessment of Cell-Mediated Cytotoxicity
At least 3 ways:
a) Mixed lymphocyte reaction (MLR)
b) Cell-mediated lympholysis (CML)
c) Delayed type hypersensitivity (DTH)
DTH - Delayed-type hypersensitivity
- DTH is a second major form of cell-mediated immunity.
- As with humoral immunity and cytotoxic T cell responses, DTH is controlled by helper T cells.
- In DTH, the effector cell is non-antigen-specific: the macrophage.
- DTH responses occur to specific types of antigen: intracellular bacteria, viruses, and certain chemicals.
-A DTH response is basically an inflammatory responseinduced by T helper cells.
- Hallmark: delay in time and recruitment of Macrophages
Antigens that induce DTH
The DTH response has two phases - sensitization and
effector phases.
Sensitization phaseoccurs on first contact with
antigen. Helper T cells are activated but mediate no DTH
response.
Langerhans cells
Fig 14-15b
Effector phase- occurs after second exposure to the antigen. Peaks at 48
hr)
T cells specific for the antigen secrete cytokines (IFN-γγγγ, TNF-β) that recruit and activate macrophages and other inflammatory cells. These cells then
mediate the DTH response.
5
DTH effector mechanisms
-IFN-gamma increases class II MHC expression on macrophagesand other cells
-IFN-gamma activates macrophages and causes them to releaseadditional inflammatory mediators
-TNF-beta mediates local tissue destruction and alters adhesion
molecules on local blood vessel endothelium to facilitateextravasation of other cells (eg neutrophils)
-IL-3 and GM-CSF enhance monocyte production by the bone